Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
ID06524505

Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression: a Double-blind, Randomized Controlled Trial

Led by Tianjin Anding Hospital · Updated on 2026-02-27

100

Participants Needed

1

Research Sites

21 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying the use of deep transcranial magnetic stimulation (dTMS) as an additional treatment for people with bipolar depression. The study aims to assess whether dTMS can improve depressive symptoms and cognitive function in these patients. This is a randomized, double-blind, sham-controlled trial involving 100 participants to evaluate the effects and tolerability of dTMS. Participants are randomly assigned to receive either active dTMS or sham (placebo) stimulation. Both groups undergo daily 20-minute sessions for five days each week over four weeks, except weekends. The active treatment uses the H1 coil delivering 55 trains of 18 Hz stimulation at 120% motor threshold, totaling 1980 pulses per session. The sham group follows the same schedule but with a sham coil that mimics the procedure without active stimulation. Throughout the study, participants have assessments at the start, after 2 weeks, 4 weeks, and 8 weeks. These include depression and anxiety rating scales, cognitive tests, and blood samples to measure brain-derived neurotrophic factor levels. Researchers will monitor symptom changes, cognitive function, and any side effects. The study concludes in February 2026, with ongoing evaluation of treatment response and safety.

CONDITIONS

Brief Title

Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Confirmed diagnosis of bipolar depression
  • Age between 18 and 65 years
  • A 17-item Hamilton Depression Rating Scale (HDRS-17) score of 17 or higher
  • Stable medication regimen maintained for at least 4 weeks before treatment
  • Minimum 4-week washout and re-evaluation after previous antidepressant therapy
Not Eligible

You will not qualify if you...

  • History of other psychiatric disorders, neurological diseases, or severe brain injury
  • Received electroconvulsive therapy, rTMS, transcranial direct or alternating current stimulation, or other neurostimulation treatments within 3 months
  • Contraindications to magnetic stimulation such as epilepsy, cardiovascular disorders, or metallic implants in the head
  • Presence of hypomanic or manic symptoms at baseline or a Young Mania Rating Scale (YMRS) score greater than 12
  • Pregnancy or lactation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 4 weeks

Participants receive daily deep Transcranial Magnetic Stimulation (dTMS) sessions or sham stimulation over four weeks, Monday through Friday. Each session lasts about 20 minutes.

20 visits (Monday to Friday for 4 weeks)

Follow-up

Duration - 4 weeks

Participants complete assessments to evaluate treatment effects and cognitive changes after the treatment period.

3 visits (at week 4, week 8, and week 8 blood collection)

Trial Site Locations

Total: 1 location

1

Tianjin Anding Hospital

Tianjin, China

Actively Recruiting

Loading map...

Research Team

J

Jie Li, Doctor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Phase 3, Randomized, Double-blind, Placebo-Controlled Stud...

Bipolar Disorder

Actively Recruiting

28 locations

Adjunctive Behavioural Activation for Bipolar Depression: A ...

Bipolar Depression

Actively Recruiting

1 location

Low-Dose Adjunctive Brexpiprazole in the Treatment of Bipola...

Bipolar Depression

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Effects of Deep Transcranial Magnetic Stimulation on Cognitive Function in Bipolar Depression: A Randomized Controlled Trial Using the MATRICS Consensus Cognitive Battery.

Lijun Chu, Xiaoju Jia, Ping Gao...

https://pubmed.ncbi.nlm.nih.gov/41788133